This article is more than 5 years old. Information may no longer be current.

MX Orthopedics announces FDA clearance for compression staple

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MX Orthopedics Corp. has announced the recent FDA clearance for its patent-pending dynaMX Compression Staple featuring malleable nitinol technology.

The dynaMX Compression Staple is indicated for fracture and osteotomy fixation of the hand and foot, joint arthrodesis of the hand and foot, and fixation of proximal tibial metaphysis osteotomy. It is the first staple to combine superelastic legs for compression with a malleable bridge that can be contoured by the surgeon to match the patient’s anatomy for improved functionality and comfort, according to a company press release.

“The dynaMX product line represents the next generation of fracture fixation and utilizes [MX Orthopedics] metallurgical and engineering expertise, resulting in simple and intuitive implants that benefit patients,” Matthew Fonte, CEO of MX Orthopedics Corp., said in the press release.

Reference: www.mxortho.com.